A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

ClinicalTrials.gov ID: NCT06439277

Public ClinicalTrials.gov record NCT06439277. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 6, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in Adolescents: A Randomized, Double-Blind, Placebo- Controlled Trial (SURMOUNT-ADOLESCENTS-2)

Study identification

NCT ID: NCT06439277
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Eli Lilly and Company; Industry
Enrollment: 300 participants

Conditions and interventions

Conditions

Interventions

Placebo Drug
Tirzepatide Drug

Drug

Eligibility (public fields only)

Age range: 12 Years to 17 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 2, 2024
Primary completion: Sep 30, 2027
Completion: Nov 30, 2030
Last update posted: Apr 19, 2026

2024 – 2030

United States locations

U.S. sites: 15
U.S. states: 9
U.S. cities: 15

Facility	City	State	ZIP	Site status
Children's Hospital Los Angeles	Los Angeles	California	90027	Active, not recruiting
Sutter Valley Medical Foundation (SVMF) Pediatric Endocrinology	Sacramento	California	95821	Active, not recruiting
Nemours Children's Health - Delaware	Wilmington	Delaware	19803	Active, not recruiting
CenExel iResearch, LLC	Decatur	Georgia	30030	Completed
Medical Research Partners	Ammon	Idaho	83406	Active, not recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago	Chicago	Illinois	60611	Active, not recruiting
Indiana University Health University Hospital	Indianapolis	Indiana	46202	Active, not recruiting
UBMD Pediatrics	Buffalo	New York	14203	Active, not recruiting
SUNY Upstate Medical University	Syracuse	New York	13210	Active, not recruiting
Driscoll Children's Hospital	Corpus Christi	Texas	78411	Active, not recruiting
Epic Medical Research - DeSoto	DeSoto	Texas	75115	Active, not recruiting
Valley Institute of Research - Fort Worth	Fort Worth	Texas	76164	Active, not recruiting
Consano Clinical Research, LLC	Shavano Park	Texas	78231	Active, not recruiting
Texas Valley Clinical Research	Weslaco	Texas	78596	Active, not recruiting
Alliance for Multispecialty Research, LLC	Layton	Utah	84041	Completed

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06439277, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 19, 2026 · Synced May 6, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06439277 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →